Advanced Parkinson's disease (PD) is frequently associated with dementia. The pathogenesis of this dementia is complex, related to deficiency of several biogenic amines and cortical Lewy body deposition, as well as co-existent age related brain changes, both of the Alzheimer's type and vascular. However, degeneration of the cholinergic neurons in the nucleus basalis of Meynert may have an important contribution to the cognitive decline. The dementia of PD has a grave effect on the quality of life of the patients and their caregivers, as well as negative effect on their survival. The treatment of dementia associated with PD therefore must encompass several agents. Cholinesterase inhibitors, such as rivastigmine, produced gratifying results. Future studies should define the exact role of this agent in the treatment of the dementia of PD.
Author information
Authors and Affiliations
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Korczyn, A. Cognitive dysfunction in Parkinson's disease. Ann Gen Hosp Psychiatry 2 (Suppl 1), S13 (2003). https://doi.org/10.1186/1475-2832-2-S1-S13
Received:
Published:
DOI: https://doi.org/10.1186/1475-2832-2-S1-S13